Farmers National Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.11M Buy
4,472
+16
+0.4% +$16.2K 0.91% 30
2025
Q4
$4.79M Buy
4,456
+345
+8% +$330K 1.07% 27
2025
Q3
$3.14M Buy
4,111
+623
+18% +$464K 0.74% 39
2025
Q2
$2.72M Sell
3,488
-65
-2% -$50.5K 0.72% 38
2025
Q1
$2.93M Buy
3,553
+569
+19% +$473K 0.83% 36
2024
Q4
$2.3M Buy
+2,984
New +$2.47M 0.67% 42
2024
Q2
$2.74M Sell
3,030
-45
-1% -$36K 0.83% 37
2024
Q1
$2.39M Buy
3,075
+6
+0.2% +$4.27K 0.71% 40
2023
Q4
$1.79M Sell
3,069
-8
-0.3% -$4.67K 0.57% 42
2023
Q3
$1.65M Sell
3,077
-44
-1% -$22.7K 0.57% 43
2023
Q2
$1.46M Sell
3,121
-64
-2% -$26.8K 0.5% 49
2023
Q1
$1.09M Sell
3,185
-115
-3% -$38.8K 0.39% 59
2022
Q4
$1.21M Sell
3,300
-90
-3% -$31.9K 0.43% 55
2022
Q3
$1.1M Sell
3,390
-184
-5% -$58.3K 0.44% 53
2022
Q2
$1.16M Sell
3,574
-80
-2% -$24K 0.44% 51
2022
Q1
$1.05M Sell
3,654
-265
-7% -$68.2K 0.36% 60
2021
Q4
$1.08M Sell
3,919
-633
-14% -$160K 0.36% 59
2021
Q3
$769K Buy
+4,552
New +$1.12M 0.31% 69
2021
Q2
Sell
-4,315
Closed -$806K 75
2021
Q1
$806K Sell
4,315
-237
-5% -$46.4K 0.31% 69
2020
Q4
$769K Buy
+4,552
New +$680K 0.31% 69
2019
Q2
$611K Sell
5,514
-380
-6% -$44.7K 0.32% 68
2019
Q1
$765K Buy
+5,894
New +$717K 0.42% 64
2018
Q2
$584K Sell
6,847
-62
-0.9% -$5.09K 0.36% 71
2018
Q1
$535K Sell
6,909
-49
-0.7% -$3.94K 0.33% 76
2017
Q4
$588K Sell
6,958
-12
-0.2% -$1.02K 0.34% 73
2017
Q3
$596K Hold
6,970
0.36% 69
2017
Q2
$574K Sell
6,970
-309
-4% -$25.2K 0.34% 70
2017
Q1
$584K Buy
7,279
+120
+2% +$9.61K 0.34% 68
2016
Q4
$527K Sell
7,159
-120
-2% -$8.94K 0.3% 74
2016
Q3
$584 Hold
7,279
0.18% 70
2016
Q2
$573K Hold
7,279
0.34% 67
2016
Q1
$524K Sell
7,279
-75
-1% -$5.67K 0.35% 69
2015
Q4
$620K Hold
7,354
0.45% 57
2015
Q3
$615K Sell
7,354
-99
-1% -$8.36K 0.49% 53
2015
Q2
$622K Hold
7,453
0.47% 56
2015
Q1
$541K Hold
7,453
0.41% 63
2014
Q4
$514K Buy
+7,453
New +$503K 0.42% 63

Other funds holding LLY

Farmers National Bank's LLY Position: Q1 2026 in Review

Farmers National Bank increased its Eli Lilly (LLY) stake by 0.36% in Q1 2026, buying an estimated $16.2K and bringing the position to 4,472 shares worth $4.11M. The position accounts for 0.91% of the portfolio, ranked #30.

Farmers National Bank first reported a position in LLY in Q4 2014 and has held it in 37 quarters since. The position peaked at $4.79M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Farmers National Bank held 4,472 shares of Eli Lilly worth $4.11M as of Q1 2026.
  • Farmers National Bank bought 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.91% of Farmers National Bank's portfolio in Q1 2026, its #30 holding.
  • Farmers National Bank first reported a position in Eli Lilly in Q4 2014 and has held it in 37 quarters since.
  • Farmers National Bank's Eli Lilly position peaked at $4.79M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Farmers National Bank's 13F filing for Q1 2026, filed 8 Jun 2026.